764 results on '"Bonavita, Simona"'
Search Results
2. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
3. Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning
4. Clinical implications for the association of psoriasis and multiple sclerosis: an observational study
5. Signs and symptoms of COVID‐19 in patients with multiple sclerosis
6. Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis
7. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
8. NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
9. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis
10. Viral pericarditis following ocrelizumab in a multiple sclerosis patient
11. MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles
12. Validation of the swallowing disturbance questionnaire in people with multiple sclerosis
13. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective
14. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis
15. Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis
16. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)
17. Machine learning techniques for prediction of multiple sclerosis progression
18. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
19. Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
20. Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab
21. Sex effects across the lifespan in women with multiple sclerosis
22. Reduced clinical connectome fingerprinting in multiple sclerosis predicts fatigue severity
23. Telemedicine application to headache: a critical review
24. Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
25. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
26. Flexibility of brain dynamics is increased and predicts clinical impairment in relapsing-remitting but not in secondary progressive multiple sclerosis
27. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
28. Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study
29. Pain, quality of life, and religiosity in people with multiple sclerosis
30. Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
31. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
32. Disability assessment using Google Maps
33. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
34. Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)
35. Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience
36. The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment
37. Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
38. Vitamin D Supplementation: Effect on Cytokine Profile in Multiple Sclerosis
39. Exercise and Parkinson’s Disease
40. Apparently isolated CNS involvement in Erdheim-Chester disease: Case report
41. Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment
42. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study
43. Correction to: Pain, quality of life, and religiosity in people with multiple sclerosis
44. Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
45. Coping strategies in relapsing–remitting multiple sclerosis non-depressed patients and their associations with disease activity
46. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
47. Psychiatric disorders in multiple sclerosis
48. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
49. Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients’ Blood
50. Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.